RGC-32 deficiency protects against hepatic steatosis by reducing lipogenesis

Journal of Biological Chemistry

Volumn 290, Issue 33, 2015, Pages 20387-20395

  Cui, Xiao Bing ^a   Luan, Jun Na ^a   Chen, Shi You ^a,b  

^a UNIVERSITY OF GEORGIA   (United States)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL ACTIVATION; ETHANOL; FATTY ACIDS; GENE EXPRESSION; INSULIN; MAMMALS;

FATTY ACID SYNTHASE; HEPATIC STEATOSIS; INSULIN RESISTANCE; LIVER X RECEPTORS; METABOLIC SYNDROMES; SIGNALING PATHWAYS; STEAROYL-COA DESATURASE; STEROL-REGULATORY-ELEMENT-BINDING PROTEIN 1C;

ENZYME INHIBITION;

ACYL COENZYME A DESATURASE 1; FATTY ACID SYNTHASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIVER X RECEPTOR; REGULATOR PROTEIN; RESPONSE GENE TO COMPLEMENT 32 PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ALCOHOL; NUCLEAR PROTEIN; ORPHAN NUCLEAR RECEPTOR; RGC-32 PROTEIN, MOUSE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ACYL COENZYME A DESATURASE 1 GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FATTY ACID SYNTHASE GENE; FATTY LIVER; GENE EXPRESSION; LIPOGENESIS; LIVER PROTECTION; MALE; METABOLIC REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C GENE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; GENETICS; KNOCKOUT MOUSE; LIPID DIET; METABOLISM; PHYSIOLOGY;

ANIMALS; DIET, HIGH-FAT; ETHANOL; FATTY LIVER; LIPOGENESIS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; NUCLEAR PROTEINS; ORPHAN NUCLEAR RECEPTORS; SIGNAL TRANSDUCTION; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 84939618773     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.630186     Document Type: Article

References (49)

1. Abdelmalek, M. F., and Diehl, A. M. (2007) Nonalcoholic fatty liver disease as a complication of insulin resistance. Med. Clin. North Am. 91, 1125-1149, ix
2. Lettner, A., and Roden, M. (2008) Ectopic fat and insulin resistance. Curr. Diab. Rep. 8, 185-191
3. Naveau, S., Giraud, V., Borotto, E., Aubert, A., Capron, F., and Chaput, J. C. (1997) Excess weight risk factor for alcoholic liver disease. Hepatology 25, 108-111
4. You, M., Fischer, M., Deeg, M. A., and Crabb, D. W. (2002) Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J. Biol. Chem. 277, 29342-29347
5. Cheung, O., and Sanyal, A. J. (2010) Recent advances in nonalcoholic fatty liver disease. Curr. Opin. Gastroenterol. 26, 202-208
6. Postic, C., and Girard, J. (2008) Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J. Clin. Invest. 118, 829-838
7. Ferré, P., and Foufelle, F. (2007) SREBP-1c transcription factor and lipid homeostasis: clinical perspective. Horm. Res. 68, 72-82
8. Dobrzyn, A., and Ntambi, J. M. (2005) Stearoyl-CoA desaturase as a new drug target for obesity treatment. Obes. Rev. 6, 169-174
9. Cohen, P., Miyazaki, M., Socci, N. D., Hagge-Greenberg, A., Liedtke, W., Soukas, A. A., Sharma, R., Hudgins, L. C., Ntambi, J. M., and Friedman, J. M. (2002) Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 297, 240-243
10. Ntambi, J. M., Miyazaki, M., Stoehr, J. P., Lan, H., Kendziorski, C. M., Yandell, B. S., Song, Y., Cohen, P., Friedman, J. M., and Attie, A. D. (2002) Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc. Natl. Acad. Sci. U.S.A. 99, 11482-11486
11. Miyazaki, M., Flowers, M. T., Sampath, H., Chu, K., Otzelberger, C., Liu, X., and Ntambi, J. M. (2007) Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis. Cell Metab. 6, 484-496
12. Badea, T. C., Niculescu, F. I., Soane, L., Shin, M. L., and Rus, H. (1998) Molecular cloning and characterization of RGC-32, a novel gene induced by complement activation in oligodendrocytes. J. Biol. Chem. 273, 26977-26981
13. Li, F., Luo, Z., Huang, W., Lu, Q., Wilcox, C. S., Jose, P. A., and Chen, S. (2007) Response gene to complement 32, a novel regulator for transforming growth factor-β-induced smooth muscle differentiation of neural crest cells. J. Biol. Chem. 282, 10133-10137
14. Fosbrink, M., Cudrici, C., Tegla, C. A., Soloviova, K., Ito, T., Vlaicu, S., Rus, V., Niculescu, F., and Rus, H. (2009) Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells. Exp. Mol. Pathol. 86, 87-94
15. Wang, J. N., Shi, N., Xie, W. B., Guo, X., and Chen, S. Y. (2011) Response gene to complement 32 promotes vascular lesion formation through stimulation of smooth muscle cell proliferation and migration. Arterioscler. Thromb. Vasc. Biol. 31, e19-26
16. Li, Z., Xie, W. B., Escano, C. S., Asico, L. D., Xie, Q., Jose, P. A., and Chen, S. Y. (2011) Response gene to complement 32 is essential for fibroblast activation in renal fibrosis. J. Biol. Chem. 286, 41323-41330
17. Fosbrink, M., Cudrici, C., Niculescu, F., Badea, T. C., David, S., Shamsuddin, A., Shin, M. L., and Rus, H. (2005) Overexpression of RGC-32 in colon cancer and other tumors. Exp. Mol. Pathol. 78, 116-122
18. Vlaicu, S. I., Tegla, C. A., Cudrici, C. D., Fosbrink, M., Nguyen, V., Azimzadeh, P., Rus, V., Chen, H., Mircea, P. A., Shamsuddin, A., and Rus, H. (2010) Epigenetic modifications induced by RGC-32 in colon cancer. Exp. Mol. Pathol. 88, 67-76
19. Kim, D. S., Lee, J. Y., Lee, S. M., Choi, J. E., Cho, S., and Park, J. Y. (2011) Promoter methylation of the RGC32 gene in nonsmall cell lung cancer. Cancer 117, 590-596
20. Cui, X. B., Luan, J. N., Ye, J., and Chen, S. Y. (2015) RGC32 deficiency protects against high-fat diet-induced obesity and insulin resistance in mice. J. Endocrinol. 224, 127-137
21. Cui, X. B., Guo, X., and Chen, S. Y. (2013) Response gene to complement 32 deficiency causes impaired placental angiogenesis in mice. Cardiovasc Res. 99, 632-639
22. Boileau, P., Wolfrum, C., Shih, D. Q., Yang, T. A., Wolkoff, A. W., and Stoffel, M. (2002) Decreased glibenclamide uptake in hepatocytes of hepatocyte nuclear factor-1α-deficient mice: a mechanism for hypersensitivity to sulfonylurea therapy in patients with maturity-onset diabetes of the young, type 3 (MODY3). Diabetes 51, S343-348
23. Li, L., Fan, D., Wang, C., Wang, J. Y., Cui, X. B., Wu, D., Zhou, Y., and Wu, L. L. (2011) Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts. Cardiovasc. Res. 91, 80-89
24. Cui, X. B., Wang, C., Li, L., Fan, D., Zhou, Y., Wu, D., Cui, Q. H., Fu, F. Y., and Wu, L. L. (2012) Insulin decreases myocardial adiponectin receptor 1 expression via PI3K/Akt and FoxO1 pathway. Cardiovasc Res. 93, 69-78
25. Mehlem, A., Hagberg, C. E., Muhl, L., Eriksson, U., and Falkevall, A. (2013) Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease. Nat. Protoc. 8, 1149-1154
26. Hofacer, R., Magrisso, I. J., Jandacek, R., Rider, T., Tso, P., Benoit, S. C., and McNamara, R. K. (2012) Omega-3 fatty acid deficiency increases stearoyl-CoA desaturase expression and activity indices in rat liver: positive association with non-fasting plasma triglyceride levels. Prostaglandins Leukot. Essent. Fatty Acids 86, 71-77
27. Tabor, D. E., Kim, J. B., Spiegelman, B. M., and Edwards, P. A. (1999) Identification of conserved cis-elements and transcription factors required for sterol-regulated transcription of stearoyl-CoA desaturase 1 and 2. J. Biol. Chem. 274, 20603-20610
28. Kim, E., Liu, N. C., Yu, I. C., Lin, H. Y., Lee, Y. F., Sparks, J. D., Chen, L. M., and Chang, C. (2011) Metformin inhibits nuclear receptor TR4-mediated hepatic stearoyl-CoA desaturase 1 gene expression with altered insulin sensitivity. Diabetes 60, 1493-1503
29. Xie, W. B., Li, Z., Shi, N., Guo, X., Tang, J., Ju, W., Han, J., Liu, T., Bottinger, E. P., Chai, Y., Jose, P. A., and Chen, S. Y. (2013) Smad2 and myocardinrelated transcription factor B cooperatively regulate vascular smooth muscle differentiation from neural crest cells. Circ. Res. 113, e76-86
30. Unger, R. H. (2002) Lipotoxic diseases. Annu. Rev. Med. 53, 319-336
31. Hulver, M. W., Berggren, J. R., Carper, M. J., Miyazaki, M., Ntambi, J. M., Hoffman, E. P., Thyfault, J. P., Stevens, R., Dohm, G. L., Houmard, J. A., and Muoio, D. M. (2005) Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans. Cell Metab. 2, 251-261
32. Warensjö, E., Ohrvall, M., and Vessby, B. (2006) Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and women. Nutr. Metab. Cardiovasc. Dis. 16, 128-136
33. Yin, H. Q., Kim, M., Kim, J. H., Kong, G., Kang, K. S., Kim, H. L., Yoon, B. I., Lee, M. O., and Lee, B. H. (2007) Differential gene expression and lipid metabolism in fatty liver induced by acute ethanol treatment in mice. Toxicol. Appl. Pharmacol. 223, 225-233
34. Wada, S., Yamazaki, T., Kawano, Y., Miura, S., and Ezaki, O. (2008) Fish oil fed prior to ethanol administration prevents acute ethanol-induced fatty liver in mice. J. Hepatol. 49, 441-450
35. Miyazaki, M., Dobrzyn, A., Man, W. C., Chu, K., Sampath, H., Kim, H. J., and Ntambi, J. M. (2004) Stearoyl-CoA desaturase 1 gene expression is necessary for fructose-mediated induction of lipogenic gene expression by sterol regulatory element-binding protein-1c-dependent and -independent mechanisms. J. Biol. Chem. 279, 25164-25171
36. Ou, J., Tu, H., Shan, B., Luk, A., DeBose-Boyd, R. A., Bashmakov, Y., Goldstein, J. L., and Brown, M. S. (2001) Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc. Natl. Acad. Sci. U.S.A. 98, 6027-6032
37. Yoshikawa, T., Shimano, H., Yahagi, N., Ide, T., Amemiya-Kudo, M., Matsuzaka, T., Nakakuki, M., Tomita, S., Okazaki, H., Tamura, Y., Iizuka, Y., Ohashi, K., Takahashi, A., Sone, H., Osuga Ji, J., Gotoda, T., Ishibashi, S., and Yamada, N. (2002) Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J. Biol. Chem. 277, 1705-1711
38. Chen, G., Liang, G., Ou, J., Goldstein, J. L., and Brown, M. S. (2004) Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc. Natl. Acad. Sci. U.S.A. 101, 11245-11250
39. Neuschwander-Tetri, B. A., and Caldwell, S. H. (2003) Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37, 1202-1219
40. Guo, S., Philbrick, M. J., An, X., Xu, M., and Wu, J. (2014) Response gene to complement 32 (RGC-32) in endothelial cells is induced by glucose and helpful to maintain glucose homeostasis. Int. J. Clin. Exp. Med. 7, 2541-2549
41. Tateya, S., Rizzo-De Leon, N., Handa, P., Cheng, A. M., Morgan-Stevenson, V., Ogimoto, K., Kanter, J. E., Bornfeldt, K. E., Daum, G., Clowes, A. W., Chait, A., and Kim, F. (2013) VASP increases hepatic fatty acid oxidation by activating AMPK in mice. Diabetes 62, 1913-1922
42. Sheng, L., Cho, K. W., Zhou, Y., Shen, H., and Rui, L. (2011) Lipocalin 13 protein protects against hepatic steatosis by both inhibiting lipogenesis and stimulating fatty acid β-oxidation. J. Biol. Chem. 286, 38128-38135
43. Lewis, G. F., Carpentier, A., Adeli, K., and Giacca, A. (2002) Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr. Rev. 23, 201-229
44. Ferré, P., and Foufelle, F. (2010) Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes. Metab. 12, 83-92
45. Shimano, H., Yahagi, N., Amemiya-Kudo, M., Hasty, A. H., Osuga, J., Tamura, Y., Shionoiri, F., Iizuka, Y., Ohashi, K., Harada, K., Gotoda, T., Ishibashi, S., and Yamada, N. (1999) Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J. Biol. Chem. 274, 35832-35839
46. Moon, Y. A., Shah, N. A., Mohapatra, S., Warrington, J. A., and Horton, J. D. (2001) Identification of a mammalian long chain fatty acyl elongase regulated by sterol regulatory element-binding proteins. J. Biol. Chem. 276, 45358-45366
47. Chakravarthy, M. V., Pan, Z., Zhu, Y., Tordjman, K., Schneider, J. G., Coleman, T., Turk, J., and Semenkovich, C. F. (2005) "New" hepatic fat activates PPARα to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab. 1, 309-322
48. Miyazaki, M., Dobrzyn, A., Sampath, H., Lee, S. H., Man, W. C., Chu, K., Peters, J. M., Gonzalez, F. J., and Ntambi, J. M. (2004) Reduced adiposity and liver steatosis by stearoyl-CoA desaturase deficiency are independent of peroxisome proliferator-activated receptor-α. J. Biol. Chem. 279, 35017-35024
49. Ge, X., Antoine, D. J., Lu, Y., Arriazu, E., Leung, T. M., Klepper, A. L., Branch, A. D., Fiel, M. I., and Nieto, N. (2014) High mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD). J. Biol. Chem. 289, 22672-22691